91AV

Introduction

Brain disorders such as: Alzheimer's disease, Parkinson's disease, epilepsy, cerebral vascular disease, including stroke, multiple sclerosis, brain trauma and migaine and their sequelae affect ~1bnpeople worldwide. The economic burden on health providers and governments is tremendous and worryingly this situation will escalate as the exected human life span increases. Throughout the world their are many interdisciplinary teams developing new therapeutic agents. Key research initiatives include: genomics, proteomics, cell imaging technologies,stem cell bioengineering, medicinal chemistry, molecular diagnostics, nanobiotechnology for drug delivery and biotherapeutics. Many significant advances have been made but still there remains a huge unmet clinical need for disease-modifying agents that will amelioare these distressing disorders.This conference will provide an unique opportunity for specialists to interact and create new collaborations. An important component of the conference is that it will provide good networking opportunities for students, to meet and question the experts and offers the chance to present a poster.

Deadlines

• Dec 03 2018
  Oral abstracts deadline

  
• Dec 03 2018
  Poster abstract deadline

  
• Dec 07 2018
  Early bird registration deadline

  

Useful links

Downloads

• 2018 neuroscience programme

Speakers

• Professor Sir Christopher Dobson University of Cambridge, United Kingdom
• Professor Sheena Radford University of Leeds, United Kingdom
• Professor Michele Vendruscolo University of Cambridge, United Kingdom
• Professor John Collinge UCL Institute of Prion Diseases, United Kingdom
• Professor Louise Serpell University of Sussex, United Kingdom
• Professor Rosemary Staniforth University of Sheffield, United Kingdom
• Doctor Peter Astles Department of Discovery 91AV Research, Eli Lilly , United Kingdom
• Doctor Dominique Lesuisse CNS Barriers Group. Sanofi,Chilly Mazarin, Fr., France

---

Venue

The 91AV

Science Room and Fish Room, The 91AV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Committee

• Doctor Irene Francois Independant Consultant, Drug Discovery and Pre-clinical Deve, United Kingdom
• Doctor Paul Race University of Bristol, United Kingdom
• Doctor Francis Lister Cancer Research UK (CRUK), United Kingdom
• Doctor Steven Bursten University of Bristol, United Kingdom

---

Contact information

Doctor Irene Francois
RSC Biotechnology Group
Furze Field Lodge
Woodlands
Send
Surrey
GU23 7LD
07776137971
Contact us by email

---